Canada's drug agency declined an interview, but said in a statement that new trial results have been published since its initial review of Wegovy in 2022
Get started with semaglutide through a guided, clinician-supported program tailored to your needs
Peptides are extremely safe for most people, with any side effects being relatively rare
Additionally, the familiar home environment can increase comfort with the process for some patients
The design of SMARRT included enrichment for a higher-risk population and employing codesigned preventive strategies personalized to the participants specific risk factors (e.g., physical inactivity, poor sleep, social isolation, smoking behavior)
Ansari S, Haboubi H, Haboubi N